Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4186713 | 0.78 | — | — | |
| SCHEMBL21276800 | 0.77 | — | — | |
| SCHEMBL13078188 | 0.74 | — | — | |
| SCHEMBL8841196 | 0.74 | — | — | |
| SCHEMBL5866468 | 0.71 | — | — | |
| SCHEMBL22696881 | 0.71 | EPHX1 (0.39) | EPHX1 | |
| SCHEMBL9619362 | 0.70 | EPHX1 (0.37) | EPHX1 | |
| SCHEMBL16572230 | 0.69 | — | — | |
| SCHEMBL3416616 | 0.67 | EPHX1 (0.39) | EPHX1 | |
| SCHEMBL1010901 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11958971-B2 | Photocurable composition, method for producing concave-convex structure, method for forming fine concave-convex pattern, and concave-convex structure | MITSUI CHEMICALS, INC. (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-110741463-B | Method for producing substrate with fine concave-convex pattern, resin composition, and laminate | 三井化学株式会社 | 2024-02-20 | — | — | CN | disclosed |
| CN-113574086-B | Photocurable composition, method for producing uneven structure, method for forming fine uneven pattern, and uneven structure | 三井化学株式会社 | 2023-11-07 | — | — | CN | disclosed |
| US-11597910-B2 | Medical instrument, cell culture method, fluorine-containing cyclic olefin polymer and fluorine-containing cyclic olefin polymer composition for it, and cultured cells | MITSUI CHEMICALS, INC. (JP) | 2023-03-07 | — | — | US | disclosed |
| US-11474429-B2 | Method of producing substrate with fine uneven pattern, resin composition, and laminate | MITSUI CHEMICALS, INC. (JP) | 2022-10-18 | — | — | US | disclosed |
| EP-3998298-A1 | PHOTOCURABLE COMPOSITION, PRODUCTION METHOD FOR UNEVEN STRUCTURAL BODY, METHOD FOR FORMING MINUTE UNEVEN PATTERN, AND UNEVEN STRUCTURAL BODY | Mitsui Chemicals, Inc. (JP) | 2022-05-18 | — | — | EP | disclosed |
| US-20220135787-A1 | PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CONCAVE-CONVEX STRUCTURE, METHOD FOR FORMING FINE CONCAVE-CONVEX PATTERN, AND CONCAVE-CONVEX STRUCTURE | MITSUI CHEMICALS, INC. (JP) | 2022-05-05 | — | — | US | disclosed |
| CN-113574086-A | Photocurable composition, method for producing uneven structure, method for forming fine uneven pattern, and uneven structure | 三井化学株式会社 | 2021-10-29 | — | — | CN | disclosed |
| CN-107429210-B | Medical device, fluorine-containing cyclic olefin polymer composition, and cell culture method | 三井化学株式会社 | 2021-05-28 | — | — | CN | disclosed |
| US-20200338807-A1 | METHOD FOR PRODUCING CONCAVE-CONVEX STRUCTURE, LAMINATE TO BE USED IN METHOD FOR PRODUCING CONCAVE-CONVEX STRUCTURE, AND METHOD FOR PRODUCING LAMINATE | MITSUI CHEMICALS, INC. (JP) | 2020-10-29 | — | — | US | disclosed |
| CN-105164559-A | Optical film | MITSU CHEMICALS INC KEIO UNIVERSITY | 2015-12-16 | — | — | CN | disclosed |
| US-20150274954-A1 | FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER COMPOSITION, IMPRINT PRODUCT OBTAINED USING THE COMPOSITION, AND METHOD FOR PRODUCING THE SAME | MITSUI CHEMICALS, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-9056938-B2 | Fluorine-containing cyclic olefin polymer composition, imprint product obtained using the composition, and method for producing the same | MITSUI CHEMICALS, INC. (JP) | 2015-06-16 | — | — | US | disclosed |
| US-20140021648-A1 | IMPRINT PRODUCT AND METHOD FOR PRODUCING THE SAME | MITSUI CHEMICALS, INC. (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20120156448-A1 | FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER COMPOSITION, IMPRINT PRODUCT OBTAINED USING THE COMPOSITION, AND METHOD FOR PRODUCING THE SAME | MITSUI CHEMICALS INC (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20110301313-A1 | IMPRINT PRODUCT AND METHOD FOR PRODUCING THE SAME | MITSUI CHEMICALS, INC. (JP) | 2011-12-08 | — | — | US | disclosed |
| US-7612123-B2 | Cyclohexene oxide compound having cyclohexyl group or long-chain alkyl group, and use thereof | TOAGOSEI CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| EP-1798251-B1 | CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR BRANCHED LONG-CHAIN ALKYL GROUP AND USE THEREOF | TOAGOSEI CO LTD (JP) | 2009-02-25 | — | — | EP | disclosed |
| US-20080108725-A1 | Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof | TOAGOSEI CO., LTD. (JP) | 2008-05-08 | — | — | US | disclosed |
| EP-1798251-A1 | CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR LONG-CHAIN ALKYL GROUP AND USE THEREOF | TOAGOSEI CO., LTD. (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108725-A1 | Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof | RAD51, HEATR1, DCXR | EPHX1 492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.